ORLANDO, Viviana
 Distribuzione geografica
Continente #
NA - Nord America 635
EU - Europa 465
AS - Asia 156
AF - Africa 15
SA - Sud America 2
Totale 1.273
Nazione #
US - Stati Uniti d'America 628
IT - Italia 337
SG - Singapore 57
IN - India 41
SE - Svezia 38
CN - Cina 31
FI - Finlandia 24
DE - Germania 16
TG - Togo 13
BG - Bulgaria 10
GB - Regno Unito 9
UA - Ucraina 9
FR - Francia 8
CA - Canada 7
ID - Indonesia 7
BE - Belgio 5
IR - Iran 5
TR - Turchia 5
RO - Romania 3
KZ - Kazakistan 2
PK - Pakistan 2
PT - Portogallo 2
RU - Federazione Russa 2
AR - Argentina 1
BD - Bangladesh 1
BH - Bahrain 1
BR - Brasile 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JP - Giappone 1
KG - Kirghizistan 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 1.273
Città #
Rome 208
Fairfield 104
Ashburn 66
Woodbridge 40
Seattle 38
Singapore 37
Cambridge 30
Wilmington 29
Chandler 28
Ann Arbor 27
Houston 25
Santa Clara 23
Princeton 19
Beijing 15
Lomé 13
Fasano 12
Helsinki 12
Plano 12
Millbury 11
San Paolo di Civitate 10
Sofia 10
Dearborn 8
Lawrence 8
New York 8
Washington 8
Jakarta 7
San Diego 7
Boston 6
Andover 5
Brussels 5
Fremont 5
Bari 4
Boardman 4
Florence 4
Istanbul 4
Norwalk 4
Salerno 4
Avellino 3
Des Moines 3
Hefei 3
Jacksonville 3
Oxford 3
Philadelphia 3
Phoenix 3
Pontelandolfo 3
Pune 3
Redwood City 3
Rogliano 3
Southend 3
Aprilia 2
Cassano delle Murge 2
Crévic 2
Dijon 2
Falkenstein 2
Frankfurt am Main 2
Kunming 2
Lappeenranta 2
Naples 2
Ottawa 2
Padula 2
Tappahannock 2
Tianjin 2
Toronto 2
Waltham 2
Wuhan 2
Abidjan 1
Absecon 1
Alatri 1
Albuquerque 1
Almaty 1
Anaheim 1
Ankara 1
Berlin 1
Bishkek 1
Bologna 1
Budapest 1
Busto Arsizio 1
Ceccano 1
Changchun 1
Chicago 1
Cinisello Balsamo 1
Dallas 1
Dublin 1
Fairview 1
Falls Church 1
Federal 1
Ferndale 1
Galdo 1
Gloucester 1
Holon 1
Liscate 1
London 1
Los Angeles 1
Milan 1
Moscow 1
Muizenberg 1
Mumbai 1
Nanjing 1
Napoli 1
New Delhi 1
Totale 963
Nome #
Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents 170
Anticancer activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a new dishevelled 1 inhibitor 121
Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies 99
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 90
Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia 83
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: Implication in peripheral inflammation 81
Exogenous control over intracellular acidification: Enhancement via proton caged compounds coupled to gold nanoparticles 66
Toward an objective evaluation of cell transfection performance 64
Modulating intracellular acidification by regulating the incubation time of proton caged compounds 62
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 61
Exogenous control over intracellular acidification: Enhancement via proton caged compounds coupled to gold nanoparticles and an alternative pathway with DMSO 60
Transfection of mouse neuroblastoma N18TG2 cells with Metafectene Pro reagent 60
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 54
Direct HPLC enantioseparation of chiral aptazepine derivatives on coated and bonded polysaccharide-based chiral stationery phases. 53
Acetylcholine induces changes in protein folding regimen and cytoskeleton organization 50
Surface functionalized multicomponent envelope type nanosystems for improved gene delivery 50
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 50
null 32
Top-down n-doped carbon quantum dots for multiple purposes: Heavy metal detection and intracellular fluorescence 28
Inflammatory cytokines and cholinergic system dis-function in multiple sclerosis patients. 12
Totale 1.346
Categoria #
all - tutte 4.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020180 0 0 0 0 0 41 32 26 26 37 8 10
2020/2021102 13 8 7 6 1 4 4 10 10 11 14 14
2021/2022248 14 3 26 10 20 8 9 18 35 17 36 52
2022/2023191 40 42 8 9 17 13 5 12 31 7 6 1
2023/2024214 18 22 14 10 14 29 18 23 12 16 25 13
2024/2025124 20 14 21 21 16 32 0 0 0 0 0 0
Totale 1.346